---
schema_version: "secwatch.filing_event.v1"
accession: "0000849146-23-000103"
form_type: "8-K"
ticker: "LFVN"
cik: "0000849146"
company_name: "Lifevantage Corp"
filed_at: "2023-08-28T23:59:59+00:00"
generated_at: "2026-06-11T03:13:36.647887+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LifeVantage Q4 revenue up 6.4% to $54.2M; declares special $0.40 dividend; FY2024 EPS guide $0.52-0.62

## Summary
- Q4 GAAP EPS $0.15 vs loss $0.11 YoY; adjusted EPS $0.17 vs $0.01; revenue $54.2M (+6.4% YoY).
- Americas revenue +17.9% (U.S. +18.6%); APAC/Europe -16.0%; total active accounts fell 8.3% to 143K.
- Declared special cash dividend of $0.40/share plus regular $0.035/share, payable Sep 22, 2023.
- FY2024 guidance: revenue $216-226M, adjusted EBITDA $16-18M, adjusted EPS $0.52-0.62 (28% tax rate).
- Strong balance sheet: $21.6M cash, no debt; FY2023 operating cash flow $6.8M.

## SEC filing metadata
- accession: 0000849146-23-000103
- form_type: 8-K
- ticker: LFVN
- cik: 0000849146
- company_name: Lifevantage Corp
- filed_at: 2023-08-28T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/849146/000084914623000103/0000849146-23-000103-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/849146/000084914623000103/lfvn-20230828.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000849146-23-000103
- JSON: https://secwatch.observer/filing/0000849146-23-000103.json
- Plain text: https://secwatch.observer/filing/0000849146-23-000103.txt

## Key facts
- Earnings Releases
  Lifevantage Corp reported fourth quarter ended June 30, 2023 results: revenue $54.2 million, net income $2.0 million, EPS $0.15 per diluted share.
  - Period: fourth quarter ended June 30, 2023
  - Revenue: $54.2 million
  - Net income: $2.0 million
  - EPS: $0.15 per diluted share
  - Result: reported results
  source text: optimal health processes, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2023. Fourth Quarter Fiscal 2023 Summary*: • Revenue of $54.2 million, an increase of 6.4% from the prior year period. Excluding the negative impact of foreign currency fluctuations, fourth quarter revenue was up approximately 7.8%; • Revenue in
  evidence_url: https://www.sec.gov/Archives/edgar/data/849146/000084914623000103/0000849146-23-000103-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.